Phase II Study of Weekly Gemcitabine and Vinorelbine for Children With Recurrent or Refractory Hodgkin's Disease: A Children's Oncology Group Report

• DOI: 10.1200/jco.2008.20.3778
• Publication Date: 2009-02-18T04:09:09Z
• Authors: Peter D. Cole; Cindy L. Schwartz; Richard A. Drachtman; Pedro A. de Alarcon; Lu Chen; Tanya M. Trippett
• Keywords: Vinorelbine; Refractory (planetary science)

The Children's Oncology Group conducted this phase II study to assess the efficacy and toxicity of gemcitabine vinorelbine (GV) in pediatric patients with heavily pretreated relapsed/refractory Hodgkin's disease. Both agents have significant single-agent response rates setting.